Besides, HTGAP patients were more likely to be accompanied with fatty liver when compared with non-HTGAP patients, and previous studies found that fatty liver probably aggravated AP through the peroxisome proliferator activated receptor alpha (PPARα) signaling pathway and fatty acid degradation pathway [39,40]. The gene discussed is PPARA; the disease is alkaline phosphatase measurement.